This article is more than 5 years old. Information may no longer be current.

Immunization: Promoting Awareness and Increasing Coverage for Pediatric Patients

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Sponsorship Statement:

This continuing medical education activity is presented by   

Produced in collaboration with

Support Statement:
This activity is supported by an educational grant from Pfizer.

Target Audience:The intended audience for the activities is pediatricians and other healthcare professionals involved in the treatment of patients with vaccine-preventable diseases. There are no prerequisites.

Overview:The development of vaccines for diseases that affect children have had a significant impact on the burdens of these diseases. An awareness of this impact and the importance of immunization is critical for health care professionals who care for these children. In this activity, leading clinicians will discuss the disease burdens of pneumococcal disease, meningitis, and rotavirus. Vaccines that prevent these diseases will be reviewed along with their impact on the disease burden, underscoring the importance of achieving high coverage rates for these vaccines.

Learning Objectives:
After attending the activity, the participant will demonstrate the ability to:

• Identify the clinical implications of known variations in the composition of different pneumococcal vaccines.
• Explain the importance of administering the pneumococcal vaccine given its observed impact on minimizing pneumococcal disease burden.
• Discuss meningococcal disease epidemiology; the safety, immunogenicity, and effectiveness of licensed meningococcal vaccines; and current immunization policy.
• Explain the disease burden of rotavirus, available rotavirus vaccines, and the importance of vaccine administration windows.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Course Chair:
Mathuram Santosham, MD, MPH
Director, Health Systems Program
Director, Center for American Indian Health
Professor, International Health and Pediatrics
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD

Faculty:
Lee H. Harrison, MD
Professor of Medicine and Epidemiology
Head, Infectious Diseases Epidemiology Research Unit
Director, Public Health Infectious Diseases Laboratory
University of Pittsburgh Graduate School of Public Health
Pittsburgh, PA

Katherine L. O’Brien, MD, MPH
Pediatrician and Professor
Department of International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD

Continuing Medical Education Information:
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

Release Date: February 21, 2011
Expiration Date: February 21, 2012
Estimated time to complete this activity: 1.5 hours

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, listen to and watch the video presentation, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, The Johns Hopkins University School of Medicine will issue an AMA PRA Category 1 Credit(s)^TM certificate.

Planning Committee and Faculty:
Mathuram Santosham, MD, MPH
Lee H. Harrison, MD
Katherine L. O’Brien, MD, MPH

Disclosures:
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME.  Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity.  Faculty are required to disclose only those relationships that are relevant to their specific presentation.  The following relationships have been reported for this activity:

Mathuram Santosham, MD, MPH (Serving as Course Director and Content Reviewer)
Grant/Research Funding (Principal Investigator): Merck
Advisory Board: Chiron, GlaxoSmithKline, Merck, Napo, Pfizer
Speaker: Chiron, GlaxoSmithKline, Merck, Pfizer

Lee H. Harrison, MD
Grant/Research Funding: Sanofi Pasteur
Consultant/Board/Honorarium: GlaxoSmithKline, Merck, Novartis Vaccines, Pfizer, Sanofi Pasteur

Katherine L. O’Brien, MD, MPH
Grant/Research Funding: Pfizer
External Expert: GlaxoSmithKline, Sanofi

The Johns Hopkins University School of Medicine and Vindico Medical Education Planning Committee report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at The Johns Hopkins University School of Medicine and Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
No speaker has indicated that he/she will reference unlabeled/unapproved uses of drugs or products.

Disclaimer Statement:
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own.  This enduring material is produced for educational purposes only.  Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach.  Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Copyright Statement:
Created and published by The Johns Hopkins University School of Medicine and Vindico Medical Education®, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2010 The Johns Hopkins University School of Medicine and Vindico Medical Education®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of The Johns Hopkins University School of Medicine or Vindico Medical Education® continuing medical education activities does not necessarily reflect the views and opinions of The Johns Hopkins University School of Medicine or Vindico Medical Education®. Neither The Johns Hopkins University School of Medicine, Vindico Medical Education®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.